Join our community at link in bio for insights on #bloodclots (#thrombosis) and #cardiovascular diseases such as #DVT, #PE, #afib, #diabetes, and #stroke.
368 Boylston St, Brookline, MA
Joined September 2009
- Tweets4.5K
- Following1.1K
- Followers3.6K
- Likes1.7K
A patient with a pulmonary embolism (PE) looks stable. But could their condition take a turn?
The 2026 AHA/ACC PE guidelines offer an updated approach to identifying patients at risk for deterioration.
📷 Hear @bbikdeli, @JaneALeopold, Lisa Moores, and Suresh Vedantham break down what this means for real-world care: tinyurl.com/y9dkmfw9
@PenVascular
#PulmonaryEmbolism #PE #Cardiology #Vasculearn
🔥 October’s What’s Hot in Clots is here!🔥
VTE’s global burden, AI for suspected PE, coated vs. uncoated aspirin, MI management, and more on catheter-directed fibrinolysis...
Read @bbikdeli's take 👇
tinyurl.com/WHICOCT
What do GLP-1s have to do with platelet activation and aggregation?
🎙️ Listen to the latest episode of the @isth The Pulse Podcast hear more from doctors Christian Ruff, @rushadpatell , and @gauer_s and explore the evolving science around GLP-1s and clotting.
Listen here: tinyurl.com/y2xbn572
@ThiemeIntl
#Vasculearn #ISTH #GLP1 #Thrombosis
When is an MI really an MI? 📷
In this WHIC Special Edition, Behnood Bikdeli, MD, MS, explores the new Fifth Universal Definition of Myocardial Infarction and what it means for diagnosis, classification, and clinical decision-making.
Read the commentary here: tinyurl.com/257uf754
#WHIC #Cardiology #MyocardialInfarction
Check out this special episode of Clot Clot, Who's There?, where we collaborated with @isth for their #ISTHPulsePodcast!
Drs. Christian Ruff and @rushadpatell talk with @gauer_s about GLP-1 use, clotting risk, implications for clinical practice, and the questions that remain.
🎧 Listen now! tinyurl.com/3xwubrve
#GLP1 #Thrombosis #ISTH
We’re exploring the evolving conversation around GLP-1 therapies and vascular health with @ISTH Pulse Podcast, including what we know and what we still need to learn about potential VTE risk.
GLP-1 receptor agonists are increasingly used in the treatment of type 2 diabetes and obesity, but what do we know about their potential relationship with venous thromboembolism (VTE)?
Tune in to a special episode of the ISTH Pulse Podcast: soundcloud.com/isth_thepulse…
When the last dose of a factor Xa inhibitor is unknown, how can clinicians determine if clinically relevant anticoagulant activity remains?
On the latest Clot, Clot, Who’s There? podcast, @AlexSpyropoul, @chrisbaugh and @DebSiegal, discuss anti-Xa testing and urgent decision-making in major bleeding and emergency surgery.
🎧Listen now: tinyurl.com/yc6sda5z
@ESCStrokeChair
#ClotClotWhoseThere #DOAC #Anticoagulation
🔥Summer may be winding down, but What’s Hot in Clots is still heating up! This month, @bbikdeli covers some of the #ESC2026 Hot Lines & more: DOACs after TAVR, LIBREXIA-ACS, anticoagulation in intermediate-risk AF, and the new universal definition of MI.
Read more 👉 tinyurl.com/59yazrf6
When urgent bleeding or surgery can’t wait, how do clinicians manage an unknown last factor Xa inhibitor dose?
Find out on the Clot, Clot, Who’s There? podcast with experts @AlexSpyropoul, @Ramacciotti_MD, and @WPHewgleyMD.
🎧 Listen now: tinyurl.com/CCWT-AUGUST
@ESCStrokeChair
🔥 A new What’s Hot in Clots is here! 🔥
When is less more—and when might more be more? @bbikdeli weighs in on:
🩸 #Aspirin deprescribing
🧠 Hemostatic profiles in ischemic #stroke
💊 DAPT vs. aspirin
❤️ OPTIMA-AF
Read more 👉 tinyurl.com/WHICAUG
🔥 Fresh from #ISTH2026: @bbikdeli's latest What's Hot in Clots just dropped!
New perspectives on:
• Aspirin vs. rivaroxaban after orthopedic surgery
• The Hydra trial
• Women's hematologic health
• Breakthrough VTE in cancer: Another look at API-CAT
Read the special ISTH edition 👉tinyurl.com/WHICISTH
@isth
#Thrombosis #VTE #Womenshealth
✈️ Heading to #ISTH2026? Your playlist starts here. 🎧
Before the meeting, catch up with the latest episodes of Clot, Clot, Who's There?:
🩸 COBRRA: What the first head-to-head DOAC trial means for practice—and what questions remain.
🧪 Bypassing Factor Xa Inhibitors: Are we measuring the right signal in major bleeding and emergency surgery?
🧠 OCEANIC-STROKE: Why Factor XI inhibition is one of the most closely watched areas in secondary stroke prevention.
🎧 Listen here: tinyurl.com/CCWTpodcast
#Thrombosis #Hemostasis #VTE #Stroke
🔥 A new month = a new What's Hot in Clots!
This month, @bbikdeli covers:
🩸 Could menaquinone-7 reignite the conversation around warfarin?
🩸 The TRACK trial fails in advanced kidney disease
🩸 A practical new NEJM review on anticoagulation reversal
🩸 New data on catheter-associated thrombosis and future directions
Read more: tinyurl.com/WHICJULY
🩸 A healthy young athlete, a sudden arm clot. The diagnosis behind the diagnosis? Often venous thoracic outlet syndrome -- underrecognized, but a leading cause of effort-related upper-extremity #DVT.
🎧 Check out a new "Clot, Clot, Who's There?" episode: tinyurl.com/CCWTJune
JoMarie Monzon, NP, @DrAliAzizzadeh, @DonnaBahroloomi, @JongkindV, @VascularSurgCS, @CedarsSinai, @amsterdamumc
🔥🩸 A new month = a new What's Hot in Clots! 🩸🔥
This month:
• Fatal PE among NCAA athletes
• Lipid-lowering therapies and VTE risk
• Gene-editing therapies targeting PCSK9
• Prasugrel after PCI?
Read @bbikdeli's latest synopsis 👇
tinyurl.com/WHICJUNE
#Thrombosis #VTE #Cardiology
‼️ New episode of Clot, Clot, Who’s There? ‼️
In urgent bleeding, PT/aPTT and anti-Xa are often the default. But are they the right signal?
Our latest episode challenges how we assess coagulation in patients on FXa inhibitors, and what may come next.
🎧 tinyurl.com/CCWT-MAY
#Thrombosis #Hematology #Cardiology
@ESCStrokeChair
May’s 🔥🩸 What’s Hot in Clots 🩸🔥 just dropped!
Along with a tribute to Dr. Braunwald, @bbikdeli brings us:
• JACC spotlight on #PE + AHA/ACC guideline
• C-TRACT → benefit
• OCEANIC-STROKE → FXIa promise (?)
• V/Q SPECT → not non-inferior
👉 Read here: tinyurl.com/WHICMAY
#Thrombosis #VTE #Cardiology